Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Testing effectiveness (Phase 2)Looking for participantsNCT06918431
What this trial is testing

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeLymphoblastic Lymphoma
City of Hope Medical Center 53
Not applicableUnknownNCT03971318
What this trial is testing

A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With LBL

Who this might be right for
Lymphoma, Non-HodgkinLymphoblastic Lymphoma, ChildhoodPTEN Loss+2 more
Sun Yat-sen University 300
Post-approval studies (Phase 4)Study completedNCT00199017
What this trial is testing

German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults

Who this might be right for
Lymphoma, Lymphoblastic
Johann Wolfgang Goethe University Hospital 75
Not applicableUnknownNCT04620655
What this trial is testing

RD13-01 for Patients With r/r CD7+ T-ALL/T-LBL

Who this might be right for
T Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
Min Xiang 24
Early research (Phase 1)Looking for participantsNCT07350863
What this trial is testing

U69-CART-Cells For R/R T-ALL

Who this might be right for
Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University 12
Early research (Phase 1)Study completedNCT04984356
What this trial is testing

Of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
Allotera Therapeutics 28
Testing effectiveness (Phase 2)Study completedNCT00199030
What this trial is testing

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

Who this might be right for
Adult Acute Lymphocytic Leukemia T-cellLymphoma, Lymphoblastic
Goethe University 8
Early research (Phase 1)WithdrawnNCT05170828
What this trial is testing

Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesT-lymphoblastic Lymphoma+4 more
Ossium Health, Inc.
Large-scale testing (Phase 3)Study completedNCT04145531
What this trial is testing

An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Leukemia
Jazz Pharmaceuticals 229
Testing effectiveness (Phase 2)Ended earlyNCT05464836
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL

Who this might be right for
Leukemia, LymphoblasticLeukemia
M.D. Anderson Cancer Center 2
Not applicableLooking for participantsNCT05626400
What this trial is testing

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

Who this might be right for
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 100
Early research (Phase 1)Study completedNCT04572308
What this trial is testing

Cell Therapy for CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD7-Specific CAR-T Cells

Who this might be right for
T-cell Acute Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 20
Not applicableUnknownNCT04679506
What this trial is testing

The Efficacy and Safety of CLAE in R/R T-ALL/LBL

Who this might be right for
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Peking University Third Hospital 50
Very early researchWithdrawnNCT04860817
What this trial is testing

Anti-CD7 CAR-T Cells in Pediatric and Young Adult Patients With Relapse and Refractory T-ALL/ T-LBL

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaT-lymphoblastic Lymphoma
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Large-scale testing (Phase 3)UnknownNCT06434467
What this trial is testing

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

Who this might be right for
T-lymphoblastic LeukemiaT-lymphoblastic Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 83
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07244380
What this trial is testing

Phase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.

Who this might be right for
T Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd. 38
Large-scale testing (Phase 3)UnknownNCT03564704
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Who this might be right for
LeukemiaLeukemia, AcuteAdult Lymphoblastic Lymphoma+5 more
Nanfang Hospital, Southern Medical University 80
Early research (Phase 1)Looking for participantsNCT06136364
What this trial is testing

CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study

Who this might be right for
T-lymphoblastic LymphomaT-ALL
Hebei Senlang Biotechnology Inc., Ltd. 9
Very early researchNot Yet RecruitingNCT07476027
What this trial is testing

Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL

Who this might be right for
T Lymphoblastic LymphomaT Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Early research (Phase 1)Not Yet RecruitingNCT07623681
What this trial is testing

Single-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

Who this might be right for
CD7+ T-ALL/LBL
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 12
Next Page